Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

NCT04749433 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped study stopped to enhance protocol and resume under different sponsor

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: [11C]CPPC Injection

Sponsor

Johns Hopkins University

Collaborators

[object Object]